Pharma

BostonGene and Takeda Collaborate to Investigate Immunotherapies through Molecular Profiling

BostonGene and Takeda Collaborate to Investigate Immunotherapies through Molecular Profiling

Shots: BostonGene & Takeda have partnered to conduct immuno-oncology focused r...

Valneva and LimmaTech Biologics Join Forces to Develop Shigella4V Against Shigellosis

Valneva and LimmaTech Biologics Join Forces to Develop Shigella4V Against Shigellosis

Shots: Valneva & LimmaTech have signed an exclusive licensing agreement to dev...

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

Shots: IDEAYA Biosciences & Biocytogen have signed an option and license agree...

GSK and Flagship Pioneering Join Forces to Discover Novel Therapeutics and Vaccines

GSK and Flagship Pioneering Join Forces to Discover Novel Therapeutics and Vaccines

Shots: GSK & Flagship Pioneering have partnered to discover & develop new...

Dren Bio Partners with Novartis to Discover and Develop Novel Targeted Myeloid Engagers for Cancer

Dren Bio Partners with Novartis to Discover and Develop Novel Targeted Myeloid Engagers for Cancer

Shots: Novartis and Dren Bio have signed a strategic collaboration to discover and...

Ipsen Collaborates with Day One Biopharmaceuticals for the commercialization of Tovorafenib to Treat Pediatric Low-Grade Glioma

Ipsen Collaborates with Day One Biopharmaceuticals for the commercialization of Tovorafenib to Treat Pediatric Low-Grade Glioma

Shots: Ipsen and Day One Biopharmaceuticals have entered into an exclusive ex-US l...

Image